Evidence map›Paper›PMID 29372256›Full record

ArticleInvestigative ophthalmology & visual science2018

Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice.

Moon K Kim, Moe H Aung, Lukas Mees, Darin E Olson, Nikita Pozdeyev, P Michael Iuvone, Peter M Thule, Machelle T Pardue

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Dopamine: A New Player in the Pathogenesis of Diabetic Retinopathy?International journal of molecular sciences · 2024
    Review
  14. Article
  15. Pig Models in Retinal Research and Retinal Disease.Cold Spring Harbor perspectives in medicine · 2024
    Review
  16. Review
  17. Article
  18. Visual Dysfunction in Diabetes.Annual review of vision science · 2023
    Review
  19. Article
  20. Annals of nuclear medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Moon K KimDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States.
Moe H AungNeuroscience, Emory University, Atlanta, Georgia, United States.
Lukas MeesDepartment of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States.
Darin E OlsonDivision of Endocrinology, Metabolism and Lipids, Emory University, Atlanta, Georgia, United States.
Nikita PozdeyevDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States.
P Michael IuvoneDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States.
Peter M ThuleDivision of Endocrinology, Metabolism and Lipids, Emory University, Atlanta, Georgia, United States.
Machelle T PardueDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States.
Emory University · USAtlanta VA Health Care System · USGeorgia Institute of Technology · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 1986 to 2025
$15.3M
Neuromodulators and Circadian Clocks: Roles in Retinal Function and DysfunctionR01EY004864 · NEI · EMORY UNIVERSITY · PI IUVONE, P MICHAEL · 1985 to 2018
$7.0M
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)R01EY021592 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H, IUVONE, P MICHAEL · 2013 to 2021
$3.3M
Dopamine treatments for diabetic retinopathyI01RX002615 · VA · VETERANS HEALTH ADMINISTRATION · PI PARDUE, MACHELLE T. · 2018 to 2021
–
NEI NIH HHS P30 EY006360NEI NIH HHS R01 EY004864NEI NIH HHS R01 EY021592RRD VA I01 RX002615
6 · The paper itself

Abstract

Purpose: Electroretinograms (ERGs) are abnormal in diabetic retinas before the appearance of vascular lesions, providing a possible biomarker for diabetic vision loss. Previously, we reported that decreased retinal dopamine (DA) levels in diabetic rodents contributed to early visual and retinal dysfunction. In the current study, we examined whether oscillatory potentials (OPs) could serve as a potential marker for detecting early inner retinal dysfunction due to retinal DA deficiency. Methods: Retinal function was tested with dark-adapted ERGs, taken at 3, 4, and 5 weeks after diabetes induction with streptozotocin. Electrical responses were analyzed and correlations were made with previously reported retinal DA levels. The effect of restoring systemic DA levels or removing DA from the retina in diabetic mice on OPs was assessed using L-3,4-dihydroxyphenylalanine (L-DOPA) treatments and retina-specific tyrosine hydroxylase (Th) knockout mice (rTHKO), respectively. Results: Diabetic animals had significantly delayed OPs compared to control animals in response to dim, but not bright, flash stimuli. L-DOPA treatment preserved OP implicit time in diabetic mice. Diabetic rTHKO mice had further delayed OPs compared to diabetic mice with normal retinal Th, with L-DOPA treatment also providing benefit. Decreasing retinal DA levels significantly correlated with increasing OP delays mediated by rod pathways. Conclusions: Our data suggest that inner retinal dysfunction in early-stage diabetes is mediated by rod-pathway deficits and DA deficiencies. OP delays may be used to determine the earliest functional deficits in diabetic retinopathy and to establish an early treatment window for DA therapies that may prevent progressive vision loss.

Indexed as

AnimalsBlood GlucoseBody WeightDark AdaptationDiabetes Mellitus, ExperimentalDiabetic RetinopathyDopamineDopamine AgentsElectroretinographyFemaleLevodopaMaleMiceMice, Inbred C57BLMice, KnockoutOscillometryBlood GlucoseDopamineDopamine AgentsLevodopaTyrosine 3-Monooxygenase

Identifiers

PMID29372256
PMCPMC5788047
OpenAlexW2787819735

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.